Newswave @ NewDelhi
Some good news regarding the novel Corona Virus. Even as the death toll is rising every day in China, the world is desperately waiting for a vaccine.
A team led by overseas doctors of India has got a major breakthrough in developing a vaccine for corona virus (2019-nCoV).
The Dangerous Pathogens team of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Australia, headed by Prof. SS Vasan, has grown the first batch of coronavirus outside China.
An alumnus of BITS Pilani and IISc-Bengaluru, Prof. Vasan completed his doctorate from Trinity College, Oxford.
The researchers at Australia’s Doherty Institute had last week managed to isolate coronavirus from a human sample. Now Prof. Vasan’s team has grown the virus in sufficient quantity needed to conduct preclinical studies. The development has gotten the world closer to a coronavirus vaccine. Professor Vasan is coordinating with several agencies to develop a vaccine for the virus. The virus has claimed 636 lives so far in China.Prof Vasan had earlier conducted research on dengue, chikungunya and zika.
Speaking of his ongoing research, Professor Vasan said: “We thank our Doherty Institute colleagues who shared their isolate with us promptly. It is quicker to work with the real virus to expedite preclinical studies on the relative efficacy of vaccine candidates under development.”
He works as the principal investigator of CSIRO’s preclinical response project in partnership with the Coalition for Emergency Preparedness Innovations (CEPI).
Shedding light on the research, Professor Vasan said: “My colleagues at the Australian Animal Health Laboratory are also working on it. They are working on diagnostics, surveillance, and response. Another part of the CSIRO (Manufacturing) is supporting the scaleup of vaccine antigens being developed by the University of Queensland.”
He added that preclinical responses to coronavirus will accelerate development to develop the vaccine. It will also carry out evaluation of therapeutics which will eventually lead to the development of a vaccine.